AI Analysis
AI-generated analysis. Always verify with the original filing.
On March 5, 2026, Jaguar Health, Inc. received a Nasdaq notice of non-compliance with Listing Rule 5550(a)(2) due to its common stock bid price closing below $1.00 for 30 consecutive business days. The Company intends to appeal by March 12, 2026, which would stay delisting pending the hearing, though success is not assured.
Key Takeaways
1Received Nasdaq Notice on March 5, 2026 for bid price below $1.00 for 30 consecutive business days
2Non-compliant with Nasdaq Listing Rule 5550(a)(2)
3Ineligible for compliance period due to prior reverse stock split(s) with cumulative ratio of 250:1 or more under Rule 5810(c)(3)(A)(iv)
4Must request appeal by March 12, 2026 or securities scheduled for delisting
5Plans to timely request appeal, staying delisting pending hearing outcome